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Abstract 
 
Normal tissues and blood have neutral pH whereas tumors and infected areas exhibit an acidic 
environment. This enables the use of drug delivery systems, for which acidification triggers the 
drug release. Liposomes are spherical bilayer structures that can entrap hydrophilic drug 
molecules. The encapsulated drug can be released e.g. by light activation, heating or upon 
acidification. The advantages of liposomes include low toxicity and biocompatibility.  
 
pH sensitive liposomes are composed of lipids that can undergo phase transition from a bilayer to 
an inverted hexagonal phase. A protonatable amphiphile, such as cholesterol hemisuccinate 
(CHEMS), stabilizes the liposome at neutral pH. In an acidic environment CHEMS becomes 
protonated, which decreases the negative charge of the membrane and leads to liposomal 
destabilization. As a result, the lipids adopt an inverted hexagonal phase and the encapsulated 
drug is released. However, the challenge is to develop liposomes that remain stable under 
physiological conditions but undergo rapid destabilization in an acidic environment.  
 
In this thesis the phase transition of pH sensitive liposomes was studied with the fluorescence 
probe Laurdan. pH sensitive 1,3-diolein-CHEMS liposomes were formulated and analyzed with 
fluorescence spectroscopy and dynamic light scattering. Fluorescence probe Laurdan that is 
sensitive to the polarity of the membrane, was used to detect the phase transition. pHrodo red was 
utilized as an additional probe to provide information about the permeability of the membrane.  
 
The results indicated that pH sensitive liposomes became unstable below pH 6.5. Particle size 
increased and Laurdan emission intensity collapsed when the liposomes were prepared at low pH. 
Also the shape of Laurdan emission peaks changed. However, the changes were not as drastic 
when liposomes were prepared under neutral conditions and pH of the external solution was 
adjusted to lower values. pHrodo red indicated that pH sensitive formulation was more permeable 
towards H+ ions than the reference liposomes.  
 
It is proposed that aggregation of the liposomes occurs at low pH. The membrane becomes more 
permeable, which enables drug leakage from the liposome. In addition, the phase behavior 
changes: the possible changes include phase separation and a phase transition from a bilayer to 
an inverted hexagonal phase.  
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Normaalien kudosten ja veren pH on noin 7.4, kun taas kasvaimissa ja tulehtuneissa kudoksissa 
on hapan pH. Tästä johtuen esimerkiksi syövän hoidossa voidaan käyttää lääkkeenkuljettajia, 
jotka vapauttavat lääkeaineen kontrolloidusti happamassa pH:ssa. Liposomit ovat pallomaisia, 
kaksikerroksisesta lipidifilmistä koostuvia rakenteita. Niiden sisään voidaan kapseloida hydrofiilisiä 
lääkeaineita. Lääkeaine voidaan vapauttaa liposomista säädellysti esimerkiksi valon, lämmön tai 
pH muutoksen avulla. Liposomit ovat kudosten kanssa yhteensopivia ja myrkyttömiä.  
 
pH herkät liposomit sisältävät lipidejä, jotka pystyvät muodostamaan käänteisen heksagonaalisen 
faasin. Protonoitu amfifiili, kuten kolesteroli-hemisukkinaatti (CHEMS), stabiloi liposomirakennetta 
neutraalissa pH:ssa. Neutraalissa pH:ssa lipidit järjestäytyvät kaksikerrosrakenteeksi. 
Happamassa ympäristössä CHEMS protonoituu, mikä vähentää lipidikalvon negatiivista varausta 
ja johtaa liposomien destabiloitumiseen. Samalla lipidit järjestäytyvät käänteiseen 
heksagonaaliseen faasiin ja myös lääkeaine vapautuu. Haasteena on kuitenkin kehittää 
liposomeja, jotka pysyvät stabiileina fysiologisissa olosuhteissa ja destabiloituvat happamassa 
pH:ssa.  
 
Tässä työssä tutkittiin pH herkkien liposomien faasimuutosta fluoresenssimerkkiaine Laurdanin 
avulla. Formuloitiin pH herkkiä 1,3-dioleiinia ja kolesteroli-hemisukkinaattia sisältäviä liposomeja. 
Liposomeja tutkittiin fluoresenssispektroskopialla ja dynaamisella valonsironnalla. Laurdan 
havaitsee lipidikaksoiskerroksen polaarisuuden muutoksia, mistä johtuen sillä voidaan tutkia 
lipidikalvon faasimuutosta. Toisena fluoresenssimerkkiaineena käytettiin pHrodo punaista, jonka 
avulla voidaan mitata solunsisäinen pH ja tutkia, kuinka hyvin protonit läpäisevät lipidikalvon.   
 
Havaittiin, että pH herkät liposomit destabiloituvat, kun pH on alle 6.5. Partikkelikoko kasvoi ja 
Laurdanin fluoresenssiemissiointensiteetti romahti, kun liposomit valmistettiin happamassa 
pH:ssa. Myös emissiopiikkien muoto muuttui. Muutokset eivät kuitenkaan olleet yhtä huomattavia, 
kun liposomit valmistettiin neutraalissa pH:ssa ja ulkoliuoksen pH säädettiin happamaksi. pHrodo 
osoitti, että pH herkkien liposomien lipidikalvo oli referenssiliposomeja läpäisevämpi H+ ioneille.  
 
Matalassa pH:ssa liposomit aggregoituvat ja membraanin läpäisevyys lisääntyy. Myös faasi 
muuttuu: mahdollisesti faasit erottuvat tai 1,3-dioleiinin faasi muuttuu kaksikerrosrakenteesta 
käänteiseen heksagonaaliseen faasiin.  
 
Avainsanat  pH herkät liposomit, faasimuutos, CHEMS, 1,3-dioleiini, Laurdan, pHrodo 
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BAM = Brewster angle microscopy 
CHEMS = cholesteryl hemisuccinate 
DAG = diacylglycerol 
DiPoPc = dipalmitoleoylphosphatidylcholine 
DiPoPE = dipalmitoleoylphosphatidylethanolamine 
DLS = dynamic light scattering  
DOPE = dioleoylphosphatidylethanolamine 
DPPC = 1,2-dipalmitoyl-sn-glycero-3-phosphocholine 
DSPC = 1,2-distearoyl-sn-glycero-3-phosphocholine 
DSPE-PEG = 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[carboxy(poly-     
ethyleneglycol)-2000] 
EPC = egg yolk phosphatidylcholine  
GP = generalised polarization 
HEPES  = 4-(2-hydrohyethyl)-1-piperazineethanesulfonic acid 
Lα = liquid-crystalline lamellar phase  
Lβ′ = gel lamellar phase 
Lyso PC = Lysophosphatidylcholine 
PC = phosphatidylcholine 
PE = phosphatidylethanolamine 
PEG = polyethylene glycol 
PSL = pH sensitive liposome            
TEM =  transmission electron microscopy                                                                       
TRIS=  Tris(hydroxymethyl)aminomethane
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1 Introduction 
Targeted drug delivery systems enable improved pharmacokinetics and 
biodistribution of the loaded drugs. Controlled release is needed for example in 
cancer treatment because conventional chemotherapy causes severe side effects. 
[1] Nanocarriers, such as liposomes accumulate in tumors after systemic 
administration [2].  Recently, liposomal drug delivery systems have been developed 
to achieve tumor specific targeting of the drug [3] [4].  
 
Liposomes are spherical bilayer structures. Hydrophilic compounds can be loaded 
inside the liposomes and a phospholipid bilayer can trap hydrophobic molecules. 
Liposomes are biocompatible and biodegradable and therefore they do not cause 
allergic or toxic reactions. [5] Yet, long circulation times and stability in biological 
fluids are needed. Lipids with polyethylene glycol (PEG) enable reduced drug 
leakage from the liposomes. [6]  
 
Drug release from the liposomes can be triggered by external or internal stimuli [7]. 
Light activation, local hyperthermia and ultrasound are examples of external stimuli.  
When combined with biosensors it is possible to obtain systems that release the 
drug upon physiological demand. Internal stimuli include pH and concentration of 
the substances. [8] [9] [10] Pathological tissues, such as tumors and inflamed areas 
have lower pH than healthy tissues [11]. pH sensitive liposomes destabilize in acidic 
environments, and therefore they can release drug content in tumors [12].  
 
The target of this master’s thesis was to study phase transition of pH sensitive 
liposomes. pH sensitive liposomes containing 1,3-diolein and cholesteryl 
hemisuccinate (CHEMS) were prepared and characterized by dynamic light 
scattering (DLS) and fluorescence spectroscopy. Previously, light activated 
liposomes were studied [13]. The hypothesis was that in acidic environments 
liposomes would become unstable and start to release their content, such as 
calcein. A change in pH would also induce phase transition, which promotes the 
drug release [14].  
 
 
 
2 
 
2 pH sensitive liposomes for controlled drug release 
pH of blood and normal tissues is ca. 7.4 [3]. However, tumors exhibit acidic pH: due 
to fast cell growth, there is not enough oxygen and nutrients. Tumor cells respond 
by changing their metabolism into anaerobic direction and the resulting lactic acid 
makes the tumor tissue acidic. [15] Modification of the liposomal composition 
enables drug release, which is triggered by environmental conditions. pH sensitive 
liposomes destabilize in acidic environments and therefore they can release their 
drug content in tumors. [12]  Moreover, inflamed or infected areas and acidic 
compartments of the cell are potential target sites for pH sensitive liposomes [11].  
 
Endosomes and lysosomes are acidic parts of the cell with pH 5-6 in endosomes 
and pH 5 in lysosomes [16]. On the other hand, lysosomes pose a risk for drug 
degradation and therefore liposomal content should be released in endosomes [17] 
[18]. Drug release can be triggered by fusion between the liposomal and endosomal 
membranes. As a result aqueous content leaks into the cytoplasm. [18] 
 
Important properties of pH sensitive liposomes include fusogenic ability, cellular 
internalization and stability in plasma and other biological fluids [12]. They can be 
divided in four different categories as follows [19]:  
 
1. Polymorphic lipids such as phosphatidylethanolamines (PE) combined with acidic 
amphiphiles. The acidic amphiphiles stabilize the liposomes at neutral pH.  
2. Liposomes with special chemical bonds, which can undergo acid-induced 
hydrolysis. This drives to membrane destabilization.  
3. Liposomes for which membrane destabilization is induced by pH sensitive 
peptides.  
4. Liposomes with pH titratable polymers. 
 
Class 1 is the most studied. It includes widely used liposomes prepared from 
dioleoylphosphatidylethanolamine (DOPE) and amphiphiles such as CHEMS or 
oleic acid. [19] In an acidic environment, protonation of the amphiphile leads to the 
loss of stabilizing negative net charge and a phase transition from lamellar to 
inverted hexagonal takes place. [19] [20] [21] However, the disadvantage is that the 
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liposomes may be eliminated from the circulation since the negatively charged 
groups, such as carboxylates, can interact with plasma proteins [1].   
 
In addition to PE, there are also other polymorphic lipids, which can be utilized in pH 
sensitive liposomes. These include diacylglycerols (DAGs) [19]. For example, 1,3- 
diolein and CHEMS are used in anionic liposomes [14] [17]. These are discussed 
further in the chapters 6.1 and 6.2.  
 
 
pH sensitive liposomes enable effective intracellular drug delivery. Still, their 
challenges include short circulation times because of recognition and sequestration 
by the reticuloendothelial system’s (RES) phagocytes. [12] One option to achieve 
longer blood circulation times is to use polyethylene glycol (PEG) or other 
hydrophilic polymers as steric stabilizers. Polymer chains of PEG form a repulsive 
barrier around the liposomes, leading to the decreased interaction with blood 
components. [4] [22] According to Hong et al. [22] DSPE-PEG improves stability of 
pH responsive liposomes in serum. On the other hand, PEG can reduce their pH 
sensitivity. Hong et al. observed that an addition of DSPE-PEG to pH sensitive 
liposomes caused a decrease in maximum leakage percentage. Their response also 
shifted to lower pH. DSPE-PEG reduces the pKa of the pH sensitive moieties, which 
leads to the poorer pH sensitivity. [22] An option to overcome the problem is to 
develop a PEG-cleavable, pH sensitive liposome system. Kanamala et al. [4] 
developed liposomes, where PEG moieties were detached from CHEMS in an acidic 
environment, generating naked DOPE/CHEMS liposomes.  
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3 Membrane processes connected to liposome 
destabilization  
Knowledge of the lipid geometry helps to predict which lipid structures are formed in 
given conditions [23]. Therefore, lipid geometry is covered before the general 
mechanisms of phase transitions and lipid membrane fusion are considered. The 
focus is on molecular level phenomena. This chapter provides background 
information for chapters, where the possible drug release mechanisms from pH 
sensitive liposomes are discussed in more detail.  
3.1 About lipid geometry  
Lipids that have a large headgroup and a relatively small hydrocarbon chain, adopt 
a cone-shaped geometry. They self-assemble into micelle structures. However, 
lipids with an equal sized headgroup and hydrocarbon moiety have cylindrical 
geometry and self-assemble into bilayers. Lipids that have small headgroup exhibit 
inverted phases including an inverted hexagonal phase and an inverted cubic 
phase. It is said that the lipids with cone-shaped geometry have a positive 
spontaneous curvature, whereas the lipids forming inverted phases have a negative 
spontaneous curvature. [23] A high negative, spontaneous curvature leads to an 
increased repulsion between hydrocarbon chains. This again increases pressure in 
the lipid chains. [24] Different lipid geometries and the predicted structures are 
presented in the Figure 1.  
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Figure 1. The effect of molecular geometry on the lipid polymorphism [23].  
3.2 Phase transition 
Understanding the dynamics of the lipids forms a basis for their applications in 
pharmaceutical and food industries [25]. The knowledge of a phospholipid main 
phase transition can be utilized, e.g. in drug delivery systems. In the previous study 
of light triggered drug delivery, drug release occurred upon the phospholipid main 
phase transition. Photothermal agents such as gold nanorods or Indocyanide Green 
molecules turned light into heat. Local heating softened the liposomal bilayer and 
drug release followed the phase transition. [13] [26] 
 
Lipid bilayers form different phases that depend on the hydration level and 
temperature. Solid gel, fluid liquid crystalline and ripple phases are examples of the 
possible phases. The main transition temperature, Tm, is a temperature where the 
phase transition from a gel to a fluid phase occurs. Below Tm, the  lipid bilayer exists 
in a more rigid gel phase. However, above Tm the fatty acid tails become more 
mobile, and the bilayer adopts a liquid crystalline phase. [25] 
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Apart from the well known gel to liquid crystalline phase transition, also different 
phase behavior is observed among the lipids. On the scope of pH sensitive 
liposomes, lamellar to non-lamellar phase transition is particularly interesting. During 
the phase transition, transformation from a bilayer to an inverted hexagonal phase 
takes place. Lamellar to non-lamellar phase transition can be induced, e.g. by acidic 
pH or by heating. [27] [21] According to Langner & Hui, [28] changes in the lipid 
packing caused by elevated stress within the matrix are the driving forces towards 
the formation of an inverted hexagonal phase. At the onset of the phase transition, 
bilayer properties alter [25]. These include defect formation and increased 
permeability towards ions [28]. Kamo et al. [29] studied structural changes in the 
molecular level even further. Before lamellar to non-lamellar phase transition, elastic 
deformation and hydrophobic hydration at the membrane surface occur. Elastic 
deformation means increased lateral pressure at the acyl chain region and it 
originates from forcing non-lamellar forming lipids to form planar structures. The 
phase transition causes a decrease in the lateral pressure. 
 
When considering membrane fusion one interesting, but less known phase is a so 
called cochleate phase. Cochleates are elongated, cylindrical lipid structures. They 
are formed when Ca2+ ions rupture lipid vesicles. According to Ramani & Balasuriam 
[30] addition of Ca2+ ions into the lipid vesicle mixture resulted in the phase transition 
from a liquid crystalline to a rigid and dehydrated (RD) cochleate phase. They 
proposed that Ca2+ ions ruptured the lipid vesicles, which lead to the formation of flat 
bilayer disks. Eventually, fusion of the disks resulted in the cochleate formation. 
 
Although cochleate formation is usually induced by Ca2+ ions [30] [31], similar 
precipitation could take place also in acidic environments. Syed et al. [32] prepared 
cochleates in acidic conditions, without multivalent cations. It is proposed that low 
pH stabilizes cochleate structures [33]. According to Binder [34] et al., phase 
separation between hexagonal and cochleate phases is connected to membrane 
fusion.   
3.3 Fusion  
Membrane fusion is a part of several cellular processes, such as secretion and 
endocytosis. In order to a fusion to occur, there must be a close approach of the two 
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fusing membranes. Also, bilayers must destabilize at the fusion point. [35] Next, the 
fusion mechanism is considered in more detail.  
 
Van der Waals attraction tends to link up the lipid membranes. Thus, van der Waals 
forces are behind membrane approach and lipid vesicle fusion. Normally a strong 
repulsive barrier that is composed of steric, electrostatic and hydration forces, 
prevents close contact between the vesicles. For example, charge loss lowers the 
repulsion and promotes aggregation. Similarly, high polarity and increased surface 
charge density prevent aggregation. [36] According to Cerv & Richardsen [36], 
formation of a new phase is not a prerequisite for membrane fusion, but the defects 
are. Accumulation of defects in the contact areas of vesicles promotes fusion. 
However, they consider that formation of a non-lamellar phase includes always 
fusion. [36] 
 
According to Bhagat and Sofou [37] fusion is initiated by vesicle contact. After that, 
the interbilayer distances decrease, which finally leads to the exchange or mixing of 
the lipids. A mechanism of the fusion is presented in Figure 2. First, aggregation 
takes place. At the membrane contact areas inverted phases can appear in the form 
of small micelles or elongated contact structures. [36]  
 
 
Figure 2. Mechanism of fusion (modified from Cerv & Richardson [36]).  
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Phosphatidylcholines and charged lipids at neutral pH act as fusion suppressing 
molecules. Phosphatidylethanolamines and diacylglycerols, on the other hand, are 
prone to fuse.  [36] 
 
To sum it up, the factors facilitating membrane fusion include formation of defects or 
non-bilayer structures, increased bilayer permeability, change in vesicle size or 
morphology and a close bilayer approach. [36] 
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4 Building blocks of liposomes 
Next, components of the pH sensitive liposomes and the reference liposomes are 
discussed in more detail.    
4.2 CHEMS   
Cholesteryl hemisuccinate (CHEMS) (Figure 3) is a protonatable amphiphile. It is 
composed of succinic acid, which is esterified to the β-hydroxyl group of cholesterol. 
Thus, it is an acidic cholesterol ester. [38] [39] 
 
 
 
Figure 3. Structure of CHEMS.  
 
According to Massey [40], the carboxyl group in CHEMS resides on the water 
interface of the lipid. Therefore, the carboxyl group increases surface charge but has 
little effect on the interfacial hydration behavior. CHEMS is widely used in pH 
sensitive liposomes containing DOPE that exhibits polymorphic phase behavior [38]. 
In CHEMS/DOPE systems, protonation state of CHEMS determines the phase [39]. 
In physiological conditions, CHEMS is negatively charged and therefore stabilizes 
DOPE that assumes a lamellar phase at neutral pH. Yet, in an acidic environment 
the stabilizing effect of CHEMS decreases and DOPE adopts an inverted hexagonal 
phase, promoting fusion. [20] [38] [41]. According to Hafez & Cullis [39] pKa of 
CHEMS is 5.8.  
 
Stabilization of the lamellar phase can be due to the repulsion between CHEMS’s 
carboxylate group and the phosphate group of DOPE [38] [41]. However, according 
to Klasczyk et al. [42], membrane-bound ions have a major role in lamellar phase 
stabilization. They observed that bilayers containing CHEMS underwent fusion even 
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at neutral or alkaline conditions when ion exchange materials immobilized the 
counter ions.   
 
Klasczyk et al. [42] also observed in their molecular dynamics simulations that 
counter ions, such as Na+ or K+, adsorb at the deprotonated carboxyl group of 
CHEMS and the bound ions became part of the head group volume. The increased 
head group size can hinder fusion and stabilize lamellar phase. When CHEMS is 
deprotonated, the carboxyl group binds two K+ or Na+ ions. [42]  
4.3 1,3-diolein 
1,3-diolein is a hydrophobic lipid which has a high negative curvature (Figure 4). It 
forms non-lamellar phases, such as an inverted hexagonal phase. [43] [29] The 
polar part of diolein is composed of a hydroxyl group. Therefore, it occupies only a 
small hydrodynamic volume. 1,3-diolein can form hydrogen bonds with adjacent 
diolein molecules or oxygen in a phospholipid, further reducing hydrodynamic 
volume. Hence, diolein promotes phase transition from a bilayer to an inverted 
hexagonal phase. [14] As stated above, lipids with small headgroups adopt inverted 
phases [23].  
 
 
Figure 4. 1,3-diolein.  
 
1,3-diolein belongs to the group of diacylglycerols that modify physicochemical 
properties of biological membranes [29]. 1,3-diolein has potential in pH sensitive 
liposomes because it can be combined with CHEMS to form a pH sensitive moiety 
in the liposomes [17] [14]. Its ability to promote membrane fusion is linked to the 
formation of inverted an hexagonal phase. Advantages of 1,3-diolein include an 
ability to remain intact in serum, while the most well-known fusogenic lipid 
component, DOPE, becomes inactive in the presence of serum. Serum proteins 
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alter bilayer composition of DOPE, which results in the loss of fusogenic properties. 
[14]  
 
Kamo et al. [43] observed that increasing the fraction of diolein in egg yolk 
phosphatidylcholine (EPC)/diolein systems leads to a higher aggregation rate and 
increased size of liposomes, which can be explained by increased hydrophobicity of 
the lipid dispersions. A higher diolein fraction also promoted the formation of non-
lamellar phases. Also, the diolein fraction determined the type of a non-lamellar 
liquid crystalline phase. EPC/diolein molar ratio of 8:2 resulted in a bicontinuous 
cubic phase, whereas higher diolein fractions lead to the formation of an inverted 
hexagonal phase (HII). [43]  
 
In further studies, Kamo et al. [29] investigated the effect of diolein on the 
membrane lateral pressure in EPC/diolein systems. During lamellar to the cubic 
phase transition, only the headgroup area exhibited transition to the cubic phase, 
but there were no changes in acyl chain packing. In the cubic phase, diolein 
increased headgroup exposure to water. The resulting hydrophobic hydration 
promoted transition to the inverted hexagonal phase. During the cubic to hexagonal 
phase transition, acyl chain packing loosened and headgroup packing increased 
further. [29] 
 
1,3-diolein and CHEMS were chosen as pH sensitive moieties. Molar ratio of 6:4 
(diolein/CHEMS) was considered to be the most suitable for pH sensitive liposomes, 
as suggested by Guo et al. [14] and Gosselin et al. [44] Hence, the same 
formulation was used also in this work, assuming that such a high diolein fraction 
would also promote the formation of an inverted hexagonal phase [29].  
4.4 Phospholipids 
Phospholipids are amphiphiles that are composed of glycerol-based lipids. They 
have two hydrocarbon chains and a hydrophilic phosphate head group [7] [25]. 
Phospholipids form the matrix of the natural membranes.  
 
At body temperature, phospholipids exist in a lamellar gel phase (Lα) or in a lamellar 
liquid crystalline phase (Lβ). The phase depends on the acyl chain length and type of 
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the polar residues. Natural membranes are composed of various types of lipids. [45] 
The behavior of the lipid matrix can be understood by studying physical and 
chemical properties of artificial, self-assembled lipid entities, such as liposomes [46] 
[47]. Artificial systems enable the control of lipid composition and environmental 
factors, including temperature and pH [47]. Lipid-lipid interactions can be understood 
by studying phase transition. [47] 
 
Parasassi et al. [48] observed that pH in the range of 4-10 did not have an effect on 
the Laurdan GP (eq.1) of phospholipid vesicles. In the later studies of pH sensitive 
liposomes, liposomes made of phosphatidylcholines (class of phospholipids) were 
used as a reference [5]. Consequently, DPPC liposomes were chosen as a 
reference system for this thesis. DPPC (Figure 5) (1,2-dipalmitoyl-sn-glycero-3-
phosphocholine) belongs to the group of phosphatidylcholines (PC). Unlike 1,3-
diolein or phosphatidylethanolamines, phosphatidylcholines are bilayer forming 
lipids [23].  
 
 
Figure 5. DPPC 
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5 Fluorescence probes to study lipid structures  
Next, the fluorescence probes used in this work are presented. They include 
Laurdan that provides information about the possible phase transition, and pHrodo 
that can offer an insight into charge transfer across the liposomal membrane. The 
principles of fluorescence are covered in the chapter 7.3.  
5.1 Laurdan 
Laurdan (6‐dodecanoyl‐2‐(dimethylamino)naphthalene) (Figure 7) is a fluorescence 
probe that is widely used to investigate phospholipid bilayers and other biological 
membranes. Laurdan is sensitive to polarity of the membrane and can therefore 
detect a phase transition in the lipid bilayer. [13] [45] [49] The mechanism can be 
explained by dipolar relaxation as follows.  
 
 
Figure 7. Fluorescence probe Laurdan [50].  
 
The fluorescent naphthalene moiety of Laurdan has a dipole moment that increases 
during excitation and can result in solvent molecule reorientation. Solvent 
reorientation requires energy, which can be observed as a shift in the emission 
spectrum. The phase of the phospholipid bilayer determines the wavelength of the 
emission maximum: a gel phase has an emission maximum at 440 nm and a liquid-
crystalline phase at 490 nm. The phase transition can thus be detected by a shift in 
the emission spectrum. In phospholipid bilayers, dipolar relaxation is due to the 
water molecules present at the glycerol backbone, where also the fluorescent 
moiety of Laurdan resides. [50] Figure 8 shows how Laurdan is located in the lipid 
bilayer. Hydrophobic interactions between the alkyl chains and Laurdan’s lauric acid 
tail anchor the fluorescence molecule into the hydrophobic core. [51] 
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Figure 8. Laurdan anchored in the lipid bilayer. Modified from Zhang et al. [51].  
 
The shift in the emission can be explained by an increased water concentration and 
improved mobility of the lipids [50]. When water molecules penetrate the loosely 
packed membrane, Laurdan emission spectrum shifts ca. 50 nm compared to the 
ordered membrane [52]. 
 
Generalized polarization (GP) can be used to quantify intensity data that is gathered 
at different emission and excitation wavelengths [45]. GP is determined as follows:  
 
      
              
           
            
 
where I440 corresponds to Laurdan emission in a gel phase and I490 in a liquid 
crystalline phase. GP values are limited in the range between −1 and 1. [45] High 
GP values indicate low water penetration and high order of the lipid membrane [52]. 
This has been proved in several studies. In the study by Viitala et al. [13] the phase 
transition of the liposomes was monitored with Laurdan. Heating liposomes to ca. 
41-43 °C resulted in a drop of the emission intensity at 440 nm and an increase at 
490 nm (Figure 9). Also, Laurdan GP decreased from ca. 0.8 to −0.2, proving that 
the phase transition had taken place.  
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Figure 9. Emission (right) and excitation (left) spectra of DPPC-Laurdan liposomes 
at different temperatures [13].  
 
In addition to Laurdan’s ability to detect phase states, it can also sense mechanical 
strain of the bilayer. Zhang et al. [51] used Laurdan to study strain of DOPC vesicles 
that was induced by osmotic pressure. Swelling of lipid vesicles increased the 
membrane tension that again decreased Laurdan GP. For 100 nm vesicles the initial 
GP value was −0.06 and after swelling −0.12. [51] However, it is worth mentioning 
that differences in the GP values are of the different order of magnitude from that 
during a phase transition from a gel to a liquid crystalline phase.  
5.1.1 Laurdan and non-lamellar forming lipids 
Although Laurdan is commonly used to study phase transitions between gel and 
liquid-crystalline phases, it can also detect phase transitions of non-lamellar forming 
lipids. [27] This makes Laurdan suitable to study pH sensitive liposomes that are 
usually composed of non-lamellar forming lipids.  
 
Epand & Leon [27] studied bilayer properties of dipalmitoleoyl phosphatidylcholine 
(DiPoPc) and dipalmitoleoyl phosphatidylethanolamine (DiPoPE) with Laurdan. 
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They found out that Laurdan could detect the formation of an inverted hexagonal 
phase of phosphatidylethanolamines, as the Laurdan GP decreased in the range of 
5-28 °C. Yet, above 28 °C, GP values started to increase and the emission intensity 
collapsed (Figure 10). [27] 
 
 
Figure 10.  Fluorescence emission spectra of Laurdan-DiPoPC (dashed lines) and 
Laurdan-DiPoPE systems (solid lines) [27]. 
 
For DiPoPc, the phase behavior was different. As temperature increased, there was 
a decrease in the Laurdan GP values. Contrary to phosphatidylethanolamines, 
phosphatidylcholine bilayers are not prone to form hexagonal phases. [27] Although 
the study performed by Epand & Leon [27] did not focus on pH, it gives fundamental 
information about the phase transition of lipids not forming lamellae. 
 
In this work, Laurdan was utilized to study phase behavior of pH sensitive 
liposomes. The target was to examine if an acidic environment can trigger a phase 
transition, similarly to light activation or heating. 
5.2 C-Laurdan 
Kim et al. [53] synthetized C-laurdan (6‐dodecanoyl‐2‐[N‐methyl‐N‐(carboxymethyl)-
amino]naphthalene) for lipid raft imaging. C-laurdan is a laurdan derivative that has 
an additional carboxyl group (Figure 11) [49]. It reflects the cell environment (fluid 
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and gel phases) accurately and is more sensitive to the membrane polarity than 
laurdan. Advantages of C laurdan include also improved water solubility. [49] [53] 
 
  
 
Figure 11. C-Laurdan.  
 
An interesting property of C-Laurdan is its ability to detect a pre-phase transition 
from a gel to a ripple phase. Traian et al. [52] observed a small slope in the GP 
values during the pre-phase transition of DPPC liposomes, and determined the pre-
phase transition temperature to be 32.8 °C. However, the transition from a gel to a 
ripple phase was not observed at an acidic pH 5.6. The result indicated that under 
acidic conditions, C-Laurdan is inserted deeper into the lipid bilayer, because the 
GP values were higher at pH 5.6 than at 7.4. [52] 
 
In this work, Laurdan-C was used as an additional fluorescence probe to study the 
phase behavior of pH sensitive liposomes.  
5.3 pHrodo red  
pHrodo red is a hydrophilic, rhodamine based fluorescence dye. Its advantages 
include good photostability and improved brightness. [54] In an acidic environment, 
fluorescence emission of pHrodo red increases remarkably. Thus, pHrodo red can 
be used to sense and image pH in cellular compartments, such as endosomes and 
lysosomes. Its pKa value is ca. 6.5. [55]  
 
When embedded in lipid vesicles, pHrodo red shows pH response from 4 to 7. 
However, the challenge is to load sufficient amounts of the fluorophore into the 
liposomes. An alternative is to link pHrodo red to a membrane forming phospholipid 
such as DOPE [54]. In an even more developed system only the inner leaflet of the 
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liposomal membrane is labeled, which minimizes background fluorescence and 
enables more reliable observations about ion transport [56]. 
 
In this work pHrodo red was used to study charge transfer through liposomal 
membrane. 
5.4 Calcein  
Calcein is a hydrophilic and self-quenching fluorescence dye, which is widely used 
to study drug release from liposomes. Calcein encapsulates in lipid vesicles at high 
concentrations (55 mM and higher [57]) where self-quenching takes place. Self-
quenching can be observed as a low fluorescence intensity. When calcein leaks out 
of the liposomes the intensity of the fluorescence signal increases notably. [5] 
 
Calcein release from the liposomes can be calculated from the following equation 
[17]:  
 
  
    
        
           (2) 
 
where R is the release percentage (%), F0 is background fluorescence (reference 
sample), F100 is fluorescence after Triton-X addition and F is fluorescence of the 
sample.   
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6 Possible mechanisms of drug release from pH sensitive 
liposomes 
In a large number of studies, liposome aggregation and model drug release from  
pH sensitive liposomes have been observed [3] [14] [58] [59]. Therefore, liposome 
aggregation and the drug release in acidic environments are discussed before 
considering the possible mechanisms of liposome destabilization in more detail.  
6.1 About liposome aggregation and drug release  
Different lipid combinations can be utilized to obtain liposomal drug release in acidic 
environments.  Fan et al. [3] used oleic acid, CHEMS and linoleic acid as  
pH sensitive molecules. Liposomes containing PE, cholesterol and pH sensitive 
molecules were analyzed at pH 5, 6 and 7.4. For PE-CHEMS liposomes, the initial 
diameter was less than 150 nm at pH 7.4, but at pH 5 the diameter increased up to 
ca. 250 nm. At low pH, CHEMS’s carboxyl group became protonated, resulting in 
decreased negative membrane charge, which again led to the liposome 
aggregation. Zeta potential measurements supported the particle analyses results: 
at physiological conditions, zeta potential of PE-CHEMS liposomes was below  
−30 mV, which indicated that negatively charged particles repelled each other. 
However, at pH 5 a slight increase in zeta potential (−25 mV) was obtained. As was 
seen from the particle size analyses, lowered negative membrane charge leads to 
the liposome coagulation. [3] 
 
Furthermore, Fan et al. [3] observed that the release of a model drug, docetaxel, 
was more rapid in an acidic environment than at neutral pH. CHEMS was the most 
suitable pH sensitive molecule for the effective drug release. During 24 hours ca. 
88% of docetaxel was released from CHEMS liposomes at pH 5, whereas 
liposomes containing linoleic acid released only 64.6%.  
 
Guo et al. [14] studied calcein release from pH sensitive DOPE/CHEMS and 
diolein/CHEMS liposomes formed with different diolein/CHEMS ratios. Liposomes 
with 6/4 diolein/CHEMS ratio were stable at physiological pH, but in an acidic 
environment (pH 5), 40% calcein was released after 30 minutes incubation at 37 °C. 
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The mean diameter of the liposomes increased from 150 nm to 1500 nm after 60 
min incubation at pH 4.8 (RT). However, at pH 5.35 and 7.4 no significant changes 
were observed. [14] Particle size analyses would be needed also at pH 5 to 
thoroughly compare drug release and aggregation.  
 
Although the combination DOPE and CHEMS in pH sensitive liposomes has been 
widely investigated there are only few studies concerning diolein. In addition to the 
studies carried out by Guo et al. [14] and Gosselin et al. [44], Lajunen et al. [17] 
utilized 1,3-diolein and CHEMS in thermo- and pH sensitive liposomes. The 
temperature gradient experiments showed that pH had an effect on liposomal 
calcein release. At pH 4.5 the most optimal formulation DPPC/DSPC/Lyso 
PC/diolein/CHEMS (10:90:15:15:10) released over 80% calcein at 45 °C. At pH 7.4, 
the release was less than 10% at the same temperature. [17] 
 
Therefore, it is evident that pH sensitive liposomes with varying lipid compositions 
can release their cargo in acidic environments. Size increase also indicates that lipid 
aggregation takes place. However, the mechanism behind the drug release remains 
unclear. When considering liposome destabilization and the consequent drug 
release under acidic conditions, two possible mechanisms have been proposed. At 
low pH, carboxyl group of amphiphile or head group of PE becomes protonated, 
which can lead to the charge loss and aggregation. [3] [58] [20] The protonation also 
promotes a phase transition from a lamellar to an inverted hexagonal phase, which 
leads to the liposome destabilization [20]. Possible mechanisms and their 
connection are discussed next in more detail.  
6.2 Charge loss and phase transition 
When considering the possible drug release mechanisms, it is important to note that 
drug release from liposomes can be significant also below the maximum 
permeability. This means that drug release begins below the main phase transition 
temperature. Heating causes premelting at the grain boundaries, which can improve 
permeability. [9] 
 
In an acidic environment, protonation of the amphiphile leads to liposome 
destabilization. Phase transition occurs since the bilayer converts into an inverted 
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hexagonal phase. [20] This indicates that the charge loss and the phase transition 
resulting from destabilization are connected. The lipid structures that are formed 
during the phase transition, are presented in Figure 12. Liposomal bilayer collapses 
during the phase transition, and the resulting lipid structures are composed of a 
monolayer. As presented in the Figure 12, hydrophobic chains are pointing outwards 
from the monolayer surface.  
 
 
 
Figure 12. Scheme of phase transition of pH sensitive liposomes containing DOPE 
[60].  
 
The fusogenic properties of the lipids can be connected to the phase transitions that 
are facilitated by high unsaturation, trans-configuration and a short lipid chain length. 
[18] Interestingly, non-bilayer structures can be important intermediates in 
membrane fusion [19] [61]. During lamellar to inverted phase transition, bilayer 
membranes transform into hexagonally packed tubes that have monolayer walls. 
The first step of the phase transition includes small connections between bilayer 
interphases. After that, the initial connections aggregate and rearrange into a 
structure with hexagonal symmetry. The same mechanism is proposed for 
membrane fusion. [61] The similarity between the mechanisms makes it probable 
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that both the membrane fusion and the phase transition take place during liposomal 
destabilization and drug release.   
 
Bambeke et al. investigated alterations in lipid organization upon acidification. They 
proposed that structural changes could be the first factor in liposomal 
destabilization. Their biophysical studies showed that leakage occurs at higher pH 
than fusion. Membrane permeabilization increased below pH 6.5 whereas the mean 
diameter of liposomes started to increase below pH 6. Lipid reorganization, resulting 
to an inverted hexagonal phase, progressed from pH 8 to 5.  
 
Although the phase transition is considered as the primary reason for drug release, 
only few studies have focused on the phase transition mechanism. Lajunen et al. 
[17] examined the phase behavior of lipid systems containing 1,3-diolein and 
CHEMS. Brewster angle microscopy (BAM) images showed that diolein/CHEMS 
moieties gave rise to the lipid domains, which caused a phase separation at pH 5 
between gel and liquid crystalline phases. The phase separation was absent at 
neutral pH and the lipids formed a homogenous, gel phase film. 1,3-diolein/CHEMS 
Langmuir films did not either have a clear collapse pressure. These results imply 
that in an acidic environment diolein/CHEMS components induced partial collapse of 
the monolayer or formed multilayers or soluble aggregates that were separated from 
the monolayer. [17] Also Karve et al. [57] studied phosphatidylcholine (PC) and 
phosphatidic acid containing lipid membranes at varying pH and observed phase 
separation. Lipid heterogeneities were formed under acidic conditions, but 
membrane permeability was improved only for lipid pairs with different acyl chain 
lengths.  
 
Also Fan et al. [3] considered the mechanism of phase transition in more detail. 
They examined the morphology of pH sensitive liposomes with transmission 
electron microscopy (TEM). In an acidic environment, the liposomes became more 
irregular and looser than in neutral conditions. At pH 5 TEM images of CHEMS 
containing liposomes showed flower-like structures, resembling the packing of 
hexagonal tubes. They proposed that a possible reason for a bilayer to hexagonal 
phase transition could be the loss of stabilizing effect of CHEMS, which was 
expected also in other studies, such as by Simoes et al. [20]. However, also head 
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group dehydration of CHEMS occurred. Dehydration changed its shape from conical 
to cylindrical, promoting phase transition. [3] 
 
Overall, it is probable that the loss of the negative charge of the liposome membrane 
promotes a phase transition from a bilayer to an inverted hexagonal phase. Yet, it is 
good to bear in mind that the most of research has focused on PE, especially on 
DOPE, and other lipids may have different mechanism. In the studies by Lajunen et 
al. [17] and Fan et al. [3] phase separation and phase transition were confirmed with 
BAM and TEM images. Fluorescence spectroscopy, however, has not been used to 
investigate the phase transition of pH sensitive liposomes containing 1,3-diolein or 
CHEMS. Therefore, Laurdan, Laurdan-C and pHrodo red were utilized in this work 
to understand the mechanism of the phase transition in more detail.  
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7 Characterization methods 
7.1 Zeta potential 
Zeta potential measurement is a common analysis method in nanoparticle surface 
characterization. Zeta potential corresponds to the potential at the slipping plane 
(Figure 13). The slipping plane determines the boundary where the particle and the 
attached ions move as one unit. Potential decreases with the distance from the 
particle surface. The highest value, surface potential, is obtained at the direct 
particle surface. Negatively charged liposome attracts positive ions that form a Stern 
layer on the surface. Beyond that, there is a more loosely packed layer, slipping 
plane, where zeta potential is measured. [62] 
 
 
 
Figure 13. Zeta potential of negatively charged liposome [62].  
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In pH sensitive liposome characterization, zeta potential provides information of the 
surface charge, which is connected, e.g. to liposome aggregation [58] [3]. Negatively 
charged liposomes can repel each other, which prevents aggregation [3].  
7.2 Dynamic Light Scattering  
Dynamic Light Scattering (DLS) or photon correlation spectroscopy (PCS) are 
common analysis methods in nanoparticle characterization. DLS measures 
Brownian motion of suspended nanoparticles. It detects particle sizes between 1-
1000 nm. It is also suitable for a broad concentration range. Because the large 
particles can mask signal of the smaller ones, the technique has limitations on the 
samples with high polydispersity.[63] 
7.3 Fluorescence spectroscopy 
Fluorescence can simply be understood as a reverse process of absorption [64]. 
Principles of fluorescence are presented in the Jablonski diagram in Figure 14. First, 
light absorption of a molecule induces electron transfer from the ground state to an 
excited state. Relaxation to the ground states includes two steps. First, an internal 
conversion takes place, i.e. the molecule releases some energy into the surrounding 
medium and returns to the first excited state. From the first excited state, it returns to 
the ground state by emitting a photon. Apart from fluorescence, there are also other 
competing processes such heat dissipation, phosphorescence and energy transfer 
to nearby molecules. [65]  
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Figure 14. Principle of fluorescence (Jablonski diagram).  
 
Since the total absorbed energy is released into the surroundings via several routes, 
the emission energy is always lower than the absorption energy [65]. Compared with 
the excitation spectrum, the emission spectrum shifts to the longer wavelengths, 
which is known as a Stoke’s shift. [64] 
 
The time scale of fluorescence depends on the electronic structure of the molecule. 
For the most fluorophores fluorescence occurs in the range of 1-100 ns. Important 
fluorescence properties include quantum yield, lifetime and intensity. Quantum yield 
describes the efficiency of a fluorophore, that is, how efficiently incoming photons 
are converted to emitted light. A fluorescence lifetime corresponds to the average 
time a fluorophore remains on the excited state. The lifetime depends on the 
emission and non-radiative relaxation that return the system to the ground state. 
Fluorescence intensity is determined by the amount of excited molecules that are 
generated upon excitation. [64] Fluorescence parameters also respond to the 
physical properties of the surroundings, and fluorescence is widely used to study 
lipid membranes. When considering the lipid behavior, such as phase coexistence 
and dynamics, fluorescence spectroscopy has a few advantages, because its time 
scale corresponds to that of membrane processes. [48] 
 
Fluorescence spectroscopy is a highly sensitive and non-destructive technique.  
Fluorometer instrumentation is composed of an excitation source, cuvette holder, 
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emission and excitation monochromators/filters, detector and recorder. Lamps or 
lasers can be used as an excitation source. [65] There are several fluorescence 
probes, which can be utilized in membrane labelling, such as Laurdan and Prodan 
[50] [13]. In this work, Laurdan and pHrodo red were used to examine membrane 
behavior of the liposomes.    
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8 Experimental  
1,3-diolein/CHEMS liposomes were prepared for the study of pH triggered drug 
delivery and plain DPPC liposomes were used as the reference in fluorescence 
measurements. In DLS and zeta potential measurements, DPPC-DSPE-PEG(2000) 
liposomes were used as the reference.  
 
DPPC (25mg/ml in chloroform), DSPE-PEG(2000) and CHEMS were purchased 
from Avanti polar lipids. Laurdan and calcein were purchased from Sigma Aldrich. 
Etax Aa was the product of Altia. pHrodo TM red dextran 10,000 MW was purchased 
from Thermo Fischer Scientific. Prof. Jan Deska kindly synthesized 1,3-diolein and 
Laurdan-C. 
 
Fluorescence measurements were carried out with Perkin Elmer LS55 fluorescence 
spectrophotometer. Particle analysis and zeta potential measurements were 
performed with Malvern Zetasizer Nano ZS.   
8.1 Liposome preparation  
Liposome samples were prepared according to ref. Viitala et al. [13] [66]. First, lipids 
(see Table 1 and Table 2) and 0.55-1 ml chloroform were added to a round flask. 
Chloroform was evaporated under nitrogen flow, and the flask was heated in a water 
path. When the temperature of 60.5 °C was reached, heating was continued for 30-
45 minutes. The dry lipid film was next hydrated with a suitable buffer (see Tables 1-
3). To ensure proper dispersion, the flask was kept in an ultrasonicator for ca. 30-45 
minutes after the lipid film was dissolved. Finally, a liposome solution was extruded 
11 times through a polycarbonate membrane with the pore size of 200 nm or 400 
nm. Extrusion temperature was ca. 61 °C. In the case of 1,3-diolein/CHEMS 
liposomes, the sample solution was first extruded through a 800 nm membrane to 
facilitate the extrusion process.  
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Figure 15. Water bath on the left and 
ultrasonicator on the right. 
Figure 16. Extrusion apparatus. 
 
When preparing liposomes for fluorescence measurements, 10 µl Laurdan/Laurdan-
C (0.2 mg/ml in ethanol) was added to the mixture (750 µl) in the first step. For 
calcein containing liposomes calcein solution (calcein 60mM, NaCl 280 mOsm pH 
7.4) was used instead of a buffer. Laurdan/Laurdan-C was not used in the calcein 
embedded liposomes. For samples containing pHrodo red, 10 µl pHrodo red 
(1mg/ml in MQ water) was added to 1ml PBS hydration buffer; they contained also 
Laurdan to make the sample visible in gel filtration.  
 
More dilute buffers (2mM Hepes 15 mM NaCl) were used in zeta potential 
measurements to prevent electrode degradation. TRIS buffer was used for 
Laurdan/Laurdan-C containing DPPC liposomes instead of HEPES because pure 
DPPC is more stable in TRIS buffer.  
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Table 1. Details of the liposomes prepared for DLS measurements.  
Liposome composition  Lipid molar ratios  Lipid conc.  Buffer 
1,3-diolein-CHEMS  60:40 3mM 20 mM Hepes 150 mM NaCl 
(pH 7.4, 6.5, 6, 5.5 or 5) 
DPPC-DSPE-
PEG2000(carboxylated) 
97:3 
 
6 mM 20 mM Hepes 150 mM NaCl 
(pH 7.4, 6, or 5) 
 
Table 2. Details of the liposomes prepared for zeta potential measurements.  
Liposome composition Lipid molar ratios  Lipid conc. Buffer 
1,3-diolein-CHEMS  60:40 3 mM 2 mM Hepes 15 mM NaCl (pH 
7.4, 6.5, 5, 5.5 or 5) 
DPPC-DSPE-
PEG2000(carboxylated) 
97:3 3 mM  2 mM Hepes 15 mM NaCl (pH 
7.4, 6.5, 5, 5.5 or 5) 
 
Table 3.  Details of the liposomes prepared for fluorescence measurements.  
Liposome composition Lipid molar 
ratios  
Lipid conc. Buffer 
1,3-diolein-CHEMS- 
Laurdan/Laurdan-C  
60:40 2 mM  20 mM HEPES 150 mM NaCl 
(pH 7.4, 6.5, 6, 5.5 or 5) 
DPPC-Laurdan/Laurdan-C  100 2 mM Tris NaCl (pH 7.4, 6 or 5) 
DPPC-1,3-diolein-CHEMS-
Laurdan 
50:30:20 2 mM 20 mM HEPES 150 mM NaCl 
(pH 7.4 or 5) 
1,3-diolein-CHEMS-
Laurdan-pHrodo red 
60:40 2 mM PBS 
DPPC-Laurdan-pHrodo red 100 2 mM  PBS  
1,3-diolein-CHEMS-calcein 60:40 2 mM PBS 
 
8.2 Preparation of buffers and other solutions  
When preparing TRIS and HEPES buffers, HEPES or TRIS and NaCl were first 
weighed and transferred into a volumetric flask. Then the volumetric flask was filled 
with MQ water to ca. 95 % of the full volume. pH was adjusted to pH 7.4, 6.5, 6, 5.5 
or 5 with HCl (1M) or with NaOH (0.5 M) and the volumetric flask was filled to the full 
volume with MQ water.  
 
PBS buffer was prepared by dissolving five tablets to 1 l of MQ water.  
 
Calcein solution was prepared by dissolving calcein and NaCl into MQ water. pH 
was adjusted to 7.4. Heating and sonication were used to dissolve calcein.  
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Laurdan and Laurdan-C were first dissolved in ethanol (Etax Aa) to obtain 
fluorophore concentration 0.2 mg/ml. Lipids in powder form, (DSPE-PEG(2000) and 
CHEMS), were diluted in chloroform. pHrodo red was dissolved in 500 µl MQ water 
to obtain concentration of 1 mg/ml.  
8.3 Liposome characterization  
8.3.1 Fluorescence  
Prior to fluorescence experiments, the samples were gel filtrated using Sephadex G-
50 column to remove an excess of a fluorophore. In practice 200-700 µl of the 
extruded and cooled liposome sample was injected into the column. UV-light lamp 
was used to distinguish Laurdan/Laurdan-C containing liposomes. The UV-visible 
fraction was gathered into five aliquots of ca. 500 µl. Sample number 4 or 5 was 
used in the fluorescence experiments. However, because of acid-induced 
destabilization, 1,3-diolein-CHEMS liposomes prepared at pH 6.5, 6, 5.5 and 5 were 
not visible in UV-light. For them fluorescence was measured from non-filtrated 
samples. To obtain comparable results, emission and excitation slits were adjusted 
to 10 nm for 1,3-diolein-CHEMS liposomes at pH 6, 5.5 and 5. Fluorescence signal 
of liposomes prepared at pH 6.5 and 7.4 was so strong that the slits were narrowed 
to 5.4 and 5.6 nm. Because of instability of the liposomes prepared below pH 6, 
fluorescence was measured from two independent liposome batches and the 
averages were used for the figures and calculation of the GP values.  
 
Due to the calcein fluorescence, calcein loaded liposomes were not visible to the 
naked eye. Yet, the liposomes were sedimenting in the column faster than free 
calcein. Thus, the liposome sample was gathered before bright orange, dilute 
calcein solution reached the bottom of the Sephadex column (Figure 17).   
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Figure 17. Gel filtration of calcein-loaded liposomes.  
 
To study release in an acidic environment, pH of the gel filtrated solution was 
adjusted with HCl (250 mM and 100 mM) to pH 5. The effect of pH on calcein 
fluorescence was minimized according to ref. [57]. After one hour incubation at T= 
37 °C, the samples were diluted with PBS buffer (pH 7.4). In practice, 20-40 µl of the 
sample (pH 5) was added to 1960-1980 µl of PBS buffer (pH 7.4). The same 
procedure was conducted also for pH 7 sample to compare release under neutral 
and acidic conditions.  
 
The reference sample was not incubated at T=37 °C but the dilution to PBS was 
similar.  
 
The sample volume for all fluorescence measurements was 450 µl. Four-window 
fluorescence cuvette (total volume 700 µl, Thorlabs) was used. For 
Laurdan/Laurdan-C containing liposomes excitation wavelength was set to 365 nm 
and the emission spectrum was recorded. For calcein loaded liposomes excitation 
wavelength was 480 nm whereas for pHrodo red containing samples excitation 
wavelength was set to 580 nm. Temperature was adjusted to 37 °C using external 
water circulation.  
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In the case of homogenous sample series, 1,3-diolein-CHEMS-Laurdan/Laurdan-C 
and DPPC-Laurdan/Laurdan-C, fluorescence was measured after ca. 15 minutes 
incubation at T = 37 °C. Measurement was repeated three times to calculate an 
average of the results.   
 
To examine how an acidic environment affects liposomal membrane, pH of external 
solution was adjusted to the lower values. In practice, 2.5-3 ml of gel filtrated 
liposome solution was mixed with 7.5-8 ml neutral buffer (see Table 1) to enable pH 
adjustment with HCl (1M, 250mM, 100mM or 25 mM). First, the neutral sample was 
measured. After that, pH was adjusted to the lower values (6.5 ,6, 5.5, 5 and 4.5). 
Samples were incubated 15 minutes at T= 37 °C before measuring fluorescence.   
8.3.2 DLS 
Particle size was analyzed with Malvern Zetasizer Nano Zs apparatus. 
Approximately 400 µl of undiluted liposome sample was pipetted into a disposable 
plastic cuvette. Size of the lipososomes was analyzed 2 x 3 times. Temperature was 
set to 25 °C. The samples were stored in refrigerator (4 °C) and they were measured 
again one and two weeks after preparation to examine stability. 
8.3.3 Zeta potential 
Zeta potential was analyzed with Malvern Zetasizer Nano ZS apparatus. Various 
dilutions and buffer salt concentrations were tested before obtaining a good 
response. In addition, disposable zeta potential cuvette was replaced with Malvern 
Zetasizer Dip Cell cuvette (ZEN1002). The final samples contained 100 µl 
liposomes and 900 µl buffer. More dilute buffers (2mM HEPES and 15 mM NaCl) 
were used in both liposome preparation and dilution to avoid electrode degradation. 
Temperature was set to 25 °C. Depending on the sample, measurement was 
repeated 1-2 x 3-5 times. 1 x 5 times was more suitable because the applied voltage 
damaged the liposomes.  
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9 Results and discussion 
9.1 Particle size analysis  
Significant changes in the particle sizes were obtained for 1,3-diolein-CHEMS 
liposomes (Figure 18). At neutral pH 7.4, the particle size was quite similar to the 
DPPC-DSPE-PEG reference samples (Figure 18) with an average diameter of 211 
nm. However, below pH 6 the particle size increased remarkably. At the day of 
preparation the average diameter of 1,3-diolein-CHEMS liposomes was 918 nm at 
pH 5. This indicated rapid aggregation or coagulation of the sample. 1,3-diolein-
CHEMS liposomes at pH 5.5 were relatively stable during the day of preparation 
with an average diameter of 390 nm. Yet, after a week the diameter was increased 
up to 900 nm. At pH 6, no remarkable changes were detected during the week.  
 
Standard deviations increased in accordance with the size enlargement, proving 
instability and heterogeneity of the sample. For nearly neutral 1,3-diolein-CHEMS 
samples (pH 7.4 and 6.5) and for DPPC-DSPE-PEG the standard deviations were 
very small, between 0.2 and 4.6, and therefore the error bars in the figures are very 
narrow.   
 
 
Figure 18. Average diameters ± standard deviations of 1,3-diolein-CHEMS and 
DPPC-DSPE-PEG liposomes at different pH.  
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Intensity distributions of 1,3-diolein-CHEMS liposomes at pH 7.4 and pH 6.5 were 
overlapping in a great extent, but under more acidic conditions the distributions were 
shifted to higher wavelengths (Figure 19). Intensity distributions of the reference 
liposomes DPPC-DSPE-PEG were overlapping at all pHs (Figure 20).  
 
.  
Figure 19. Intensity distributions of 1,3-
diolein-CHEMS liposomes at different pH.  
 
Figure 20. Intensity distributions of 
DPPC-DSPE-PEG liposomes at different 
pH. 
 
After two weeks the particle sizes of DPPC-DSPE-PEG liposomes remained 
unaltered but 1,3-diolein-CHEMS liposomes showed great degradation under acidic 
conditions (Table 4). In addition to the very large particles, also small structures 
were detected. This could have been due to the destabilization and precipitate 
formation. However, at pH 7.4 and 6.5 no significant changes took place.  
 
Considering the stability of the neutral 1,3-diolein-CHEMS liposomes, it is 
remarkable that the particle size remained unaltered for two weeks. In this respect, it 
could be possible to obtain a stable formulation at physiological conditions without 
PEG.  However, it should be noted that the liposome samples were stored at  
T = 4 °C, which does not correspond physiological conditions.  
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Table 4. Average diameters of the liposomes two weeks after preparation.   
Liposomes  pH  Average diameter  
DPPC-DSPE-PEG  7.4  155 
DPPC-DSPE-PEG  6 147 
DPPC-DSPE-PEG  5 149 
1,3-diolein-CHEMS  7.4  206 
1,3-diolein-CHEMS 6.5  240 
1,3-diolein-CHEMS  6 324 
1,3-diolein-CHEMS  5.5  8000 
 
In conclusion, the average diameters of 1,3-diolein-CHEMS liposomes were strongly 
dependent on pH. The results were in line with the other studies, where liposome 
enlargement in acidic environment was observed [14] [3].   
9.2 Zeta potentials 
Zeta potentials of homogenous 1,3-diolein-CHEMS and DPPC-DSPE-PEG liposome 
samples are shown in Figure 21. Zeta potential of 1,3-diolein-CHEMS liposomes 
was clearly negative with ca. −70 mV at pH 7.4 and −59 mV at pH 5. Considering 
the pH scale between pH 7.4 and 5, the zeta potential was constantly increasing but 
the changes were not very big. This could be due to the protonation behavior of 
CHEMS: with pKa of 5.8 [39] more acidic environment would be needed to cause a 
more drastic increase in zeta potential. It is also possible that the ion content of the 
buffer affected the results. When pH of external solution was adjusted to the pH 
4.36, remarkable increase of zeta potential was detected (Figure 22). For the 
experiment, the liposomes were prepared at pH 7.4 and pH of the external solution 
was lowered to the desired values.  
 
In a case of DPPC-DSPE-PEG, the slightly negative zeta potentials, −22 mV at pH 
7.4 and −16 mV at pH 5 were probably due to the carboxyl group of PEG.  
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Figure 21. Zeta potentials and standard deviations of 1,3-diolein-CHEMS and 
DPPC- DSPE-PEG.  
 
 
Figure 22. Zeta potentials of 1,3-diolein-CHEMS liposomes when pH of external 
solution was adjusted to lower values.  
 
The zeta potential results supported the hypothesis that the negative charge of the 
liposomal membrane decreases upon acidification. The results were in accordance 
with Fan et al. [3], who also observed a decrease in the absolute value of zeta 
potential. For CHEMS containing liposomes, zeta potential was a bit below −30 mV 
at pH 7.4 and −25 mV at pH 5 [3]. However, they used PE instead of 1,3-diolein, 
which can explain the higher values.  
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9.3 Fluorescence experiments 
9.3.1 Homogenous series 
Fluorescence spectra of Laurdan-containing, homogenous 1,3-diolein-CHEMS 
liposomes are shown in Figure 23. Emission spectra of Laurdan and DPPC 
containing reference liposomes were overlapping at pH 5, 6 and 7.4 (Figure 24). 
Therefore, Laurdan is well suitable to study pH induced changes in the membrane 
behavior in the pH range of 5-7.4.  
 
 
Figure 23. Emission spectra of 1,3-
diolein-CHEMS-Laurdan liposomes at 
different pH at T = 37 °C.  
 
Figure 24. Emission spectra of DPPC- 
Laurdan liposomes at different pH at  
T = 37 °C .  
 
Higher intensity of 1,3-diolein-CHEMS pH 6.5 sample is due to the gel filtration of 
the sample prepared at pH 7.4. Below pH 6.5, the emission intensity collapsed and 
shape of the emission peaks changed. This shows that membrane properties of 1,3-
diolein-CHEMS liposomes alter in acidic environments. The intensity drop at 440 nm 
indicates that the gel phase disappears at low pH values. Yet, the phase behavior 
deviates from that of liposomes that exhibit a phase transition from a gel to a liquid 
crystalline phase. During heating, when a phase transition of DPPC containing 
liposomes occurred, emission intensity at ca. 490 nm increased while intensity at 
440 nm collapsed [13]. In the case of 1,3-diolein-CHEMS liposomes also intensity at 
490 nm dropped in acidic environments, indicating that a phase transition from a gel 
to a liquid crystalline phase does not take place. However, Epand et al. [27], who 
studied non-lamellar forming lipids, observed similar changes in the emission 
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spectrum when the system was approaching the hexagonal phase transition 
temperature. Emission intensity collapsed and the spectrum resembled that of 
Laurdan in a buffer. Therefore, it is suggested that 1,3-diolein-CHEMS lipid system 
adopts an inverted hexagonal phase in acidic environments.   
 
In addition to the peaks corresponding gel and liquid crystalline phases, also a third 
emission peak at n. 420 nm was observed below pH 6.5. The third peak becomes 
even more evident as pH drops. One possibility is that it is due to precipitate 
formation. Ramani & Balasuriam [30] observed also third peak at 425 nm in a study 
where they examined cochleate structures with Laurdan. In the emission spectrum, 
the phase transition from a liquid crystalline to a rigid and dehydrated cochleate 
phase was detected as a shift from 490 nm to 425 nm. Therefore, it is possible that 
similar precipitates are formed also in acidic conditions. In addition, phase 
separation between an inverted hexagonal and a rigid, dehydrated phase can 
explain the shape of the emission peaks.  
 
In addition to the drop of emission intensity, slight decrease in the Laurdan GP 
values was observed (Figure 25). This deviates from the results obtained by Epand 
et al. [27] who observed a slight increase in GP values during a lamellar to 
hexagonal phase transition. However, as Epand et al. [27] denoted, low 
fluorescence intensity makes the GP values less accurate. Different lipid 
compositions were also used in this work.  
 
 
Figure 25. GP-values for 1,3-diolein-CHEMS-Laurdan liposomes at different pH.  
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Considering the GP values and the shape of the emission peaks, there are 
significant differences between 1,3-diolein-CHEMS and DPPC liposomes. For 
diolein-CHEMS liposomes, the peak is boarder already at neutral pH, indicating a 
less ordered membrane. This is confirmed with the GP values: for 1,3-diolein-
CHEMS GP is 0.29 at pH 7.4 whereas GP value of DPPC liposomes at the same 
conditions is 0.45.  
 
Emission spectra of Laurdan-C containing 1,3-diolein-CHEMS liposomes are shown 
in Figure 26. The results are in line with those obtained with Laurdan. Yet, Laurdan-
C labeled liposomes showed slightly greater decrease in the GP values (Figure 28). 
This could be due to the improved ability of Laurdan-C to detect pre-phase transition 
[52]. However, DPPC-Laurdan-C reference samples showed also pH dependency, 
although it was different to that of pH sensitive formulation. Under acidic conditions, 
the emission peaks of DPPC-Laurdan-C liposomes narrowed and shifted to slightly 
shorter wavelengths (Figure 27). The emission intensity remained unaltered. The 
changes were probably due to the protonation of carboxyl group of Laurdan-C.  
 
 
Figure 26. Emission spectra of diolein-
CHEMS-Laurdan-C liposomes at 
different pH.  
 
 
Figure 27. DPPC Laurdan-C liposomes at 
different pH.  
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Figure 28. GP-values for 1,3-diolein-CHEMS-Laurdan-C liposomes at different pH.  
 
When 1,3-diolein and CHEMS moieties were combined with DPPC, the formulation 
showed no remarkable pH dependency. As seen from the Figure 29, the emission 
peak of the liposomes prepared at pH 5 was slightly narrowed. Intensity collapse 
was absent, which indicates that 50 % DPPC suppressed pH sensitivity of the 
system. At pH 7.4 GP value was 0.35 whereas at pH 5 it was 0.43.  
 
Figure 29. Laurdan containing DPPC-diolein-CHEMS (50:30:20) liposomes 
prepared at pH 7.4 and pH 5.  
 
In the particle size analyses, there was only a small increase in the average particle 
size, with 183 nm at pH 7.4 and 230 nm at pH 5. Possibly 1,3-diolein and DPPC 
formed a bilayer structure at neutral pH, causing a broader emission peak than that 
of pure DPPC. However, when the protonation behavior of CHEMS changed, it did 
not cause a phase transition of the lipid system. 1,3-diolein-CHEMS moieties could 
have been separated from the DPPC bilayer structure that remained unaltered in an 
acidic environment.  
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Although the goal of the work was to study how pH affects liposomal membrane, 
heating experiments provided additional information of the phase behavior. Figure 
30 shows that 1,3-diolein-CHEMS liposomes respond to heating differently from 
DPPC vesicles. For both Laurdan and Laurdan-C containing DPPC liposomes, 
collapse of GP values is observed at ca. T = 42-43 °C where the phase transition 
takes place [13]. However, for Laurdan containing 1,3-diolein-CHEMS liposomes the 
GP value decrease slowly from 0.34 at T = 25 °C to 0.16 at T = 70 °C. This indicates 
that the phase transition is not as sharp as for DPPC liposomes.   
 
 
Figure 30. GP values of Laurdan/Laurdan-C containing reference liposomes and 1,3 
diolein-CHEMS liposomes during heating.  
9.3.2 Liposomal response for lowered pH of external solution 
To obtain a homogenous series, liposomes were prepared in acidic conditions that 
are not suitable for drug delivery. Therefore, in addition to the homogenous series, 
phase behavior of Laurdan containing 1,3-diolein-CHEMS liposomes was examined 
upon lowering the pH of an external solution. For the experiments, the liposomes 
were prepared at pH 7.4. The results are presented in the Figures 31-33. Although 
the emission intensity dropped at an acidic pH, the changes are not as remarkable 
as those obtained by the homogenous series. After two weeks storage at RT the 
shape of the peaks at pH 5.5 and 5 were quite similar to the homogenous series. 
White precipitates were observed by naked eye. It is interesting that after one week 
at RT, the emission of pH 5.1 sample is lower than that of pH 4.5 sample. According 
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to Lee & Thompson [67] the ability of diacylglycerols to promote bilayer 
destabilization, including phase transition to inverted hexagonal phase, and vesicle 
fusion is maximized at pH 5. Therefore, the pH sensitive point of the formulation 
could be around 5. 
 
 
Figure 31. Emission spectra of 1,3-diolein-CHEMS-Laurdan sample at different pH. 
 
 
Figure 32. Emission spectra of 1,3-
diolein-CHEMS-Laurdan samples after 
one week at RT.  
 
 
Figure 33. Emission spectra of 1,3-diolein-
CHEMS-Laurdan samples after two weeks 
at RT. 
 
The GP values of the samples increased slightly upon acidification as shown in 
Figure 34. However, below pH 5 the values started to decrease after ca. 24 hours of 
preparation. Also, at pH 5 the GP value decreased slightly after two weeks at RT. 
Interestingly, this deviates from the results obtained from the homogenous series, 
where a slight decrease in the GP values was observed. However, when the shape 
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of the peaks become similar to that of the homogenous series, also the GP values 
start to decrease. One possible reason could be that first the lower pH leads to 
tighter packing of the lipid membrane. After that, the sample starts to degrade and 
undergoes a phase transition.  
 
 
Figure 34. Laurdan GP values of 1,3-diolein-CHEMS systems.  
 
pHrodo red was used to study proton transfer across the liposomal membrane. 
Figures 35-36 show that particularly at low pH there were differences between 1,3-
diolein-CHEMS and DPPC liposomes. In the case of DPPC liposomes, the changes 
in emission intensity are smaller, which is probably due to a higher pH inside the 
liposomes. The membrane of 1,3-diolein-CHEMS liposomes is more permeable 
towards H+ ions and therefore the intracellular pH becomes more acidic as pH of the 
external solution drops. The sensitivity of pHrodo red declines towards pH 4, as 
shown in the Figure 37. Thus, the emission intensities overlap for DPPC-pHrodo red 
system at pH 5, 5.5 and 4.5. Because of a lower intracellular pH, the emission 
intensities of pHrodo red in 1,3-diolein-CHEMS liposomes were distinguishable also 
at low pH. 
 
Overall, the emission spectra of pHrodo red containing 1,3-diolein-CHEMS 
liposomes are more close to pHrodo red in buffer than that of DPPC liposomes. This 
supports the suggestion that the membrane of 1,3-diolein-CHEMS liposomes is 
more permeable towards H+ ions than the DPPC membrane. Because of relatively 
small differences in the intensities, the measurements were repeated with fresh 
liposome batches to confirm the results. The average diameter of pHrodo red 
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containing 1,3-diolein-CHEMS liposomes increased upon acidification. The initial 
diameter was 206 nm at pH 7.2 whereas at pH 4.9 the diameter was 486 nm. 
 
 
 
Figure 35. pHrodo red containing 1,3-
diolein-CHEMS liposomes at different 
pH. 
Figure 36. pHrodo red containing DPPC 
liposomes at different pH.  
 
 
 
Figure 37. pHrodo red in PBS buffer.   
 
It is worth noting that the phase transition occurs more slowly than charge transfer 
across the membrane. The change in the phase behavior is not close to the 
homogenous sample series until after two weeks at room temperature. Therefore, it 
is possible that release occurs already at the pre-phase transition. Another option is 
that the liposomes encapsulate the drug but the release remains inefficient. In 
cancer treatment, the goal of pH sensitive liposomes is to release their content 
already in endosomes, before possible degradation in lysosomes [68] [41]. For this, 
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the phase transition is too slow, at least if the drug release is not sufficient already 
during pre-phase transition.  
 
To obtain a more profound understanding about the drug release and its connection 
to lipid membrane behavior, calcein release experiments were performed. Calcein 
fluorescence showed pH dependency and therefore different sample preparation 
procedures were tested. With an adequate dilution, the effect of pH on calcein 
fluorescence was minimized.  
 
Calcein fluorescence assay showed that calcein was encapsulated efficiently in the 
1,3-diolein-CHEMS liposomes (Figure 38). At pH 7.25, before addition of Triton-X, 
fluorescence intensity of the sample was small. Triton-X ruptured the lipid 
membrane, which resulted in calcein release from the liposomes. Calcein release 
was observed as an increased fluorescence intensity. The capability to encapsulate 
calcein also indicates that 1,3-diolein-CHEMS lipid systems form vesicle structures 
in a neutral environment.  
 
 
Figure 38. Calcein release from 1,3-diolein CHEMS liposomes after addition of 
Triton-X. 
 
After one hour incubation at T = 37 °C 10.1 % of encapsulated calcein was released 
at pH 4.8. At pH 7.3, the release was 4.1 %. After one day storage at RT the release 
percentage was 37.8 % at pH 4.8 and 19.4 % at pH 7.3. All the results are 
presented in Table 5. The release percentages were calculated from eq. 2. The 
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release was well below the release percentages obtained by Guo et al. [14] who 
used the same lipid combination in pH sensitive liposomes. It is possible that the 
effect of pH on calcein fluorescence was not completely eliminated. The lower 
release percentage could also have been due to different liposome preparation 
method or dilution of the sample solution upon HCl addition. In addition, the 
fluorescence following Triton-X addition was varying upon time. Therefore, the 
release percentages presented in the table are only approximate.  
 
Table 5. Calcein release from 1,3-diolein-CHEMS liposomes                   
Time   pH  Release % 
Day 1  4.8 10.1 
Day 1  7.3 4.1 
Day 2  4.8 37.8 
Day 2 7.3 19.4 
Day 1  5 8.5 
Day 1  7.3 2.3 
 
To obtain more reliable results, some calibration method could be used to remove 
the effect of pH on calcein fluorescence. Also, the formulation of the liposomes 
could be improved to minimize drug leakage at neutral pH and improve the release 
under acidic conditions.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
48 
 
10 Conclusions  
As a summary, DLS and fluorescence experiments indicate that 1,3-diolein-CHEMS 
liposomes become unstable below pH 6.5. Size enlargement begins at pH 6 and 
becomes even more remarkable as pH drops. In a similar fashion emission spectra 
of homogenous 1,3-diolein-CHEMS fluorescence samples show little variation 
between pH 6.5 and 7.4. Yet, at pH 6, the intensity drops significantly and shape of 
the peaks change. Fluorescence experiments carried out with pHrodo showed that 
the membrane of 1,3-diolein-CHEMS liposomes is more permeable towards H+ ions 
than the DPPC membrane. Thus, in acidic environments liposomes aggregate and 
their phase behavior changes. The results also proved that Laurdan is a suitable 
fluorescence probe to study pH induced changes in liposomal membrane.  
 
The phase transition of 1,3-diolein-CHEMS liposomes deviates from that of light or 
heat activated liposomes [13]. The differences are due to the different lipids used in 
the formulations. Unlike phospholipids, the lipids adopting inverted phase structures 
can undergo acid induced destabilization. Instead of a gel to a liquid crystalline 
phase transition, 1,3-diolein can transform from a bilayer to an inverted hexagonal 
phase [14]. The changes in the phase behavior are observed as collapsed Laurdan 
emission intensity.  
 
For further research, a microscope technique such as Cryo-transmission electron 
microscopy (Cryo-TEM) could be utilized to acquire more information about the lipid 
structures and to confirm formation of inverted hexagonal phase structures. Cryo-
TEM technique is suitable for aqueous, dilute solution [35]. In addition, it does not 
rupture the lipid vesicles [66]. 
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pH dependency of calcein                                                          APPENDIX  1.   
 
 
Figure. Fluorescence spectra of 1,3-diolein-CHEMS calcein samples at different 
pHs, when the effect of pH on calcein fluorescence was not minimized. Complete 
calcein release was achieved with Triton-X.  
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